New User? Sign Up | Sign In

Insider Trading - Bellerophon Therapeutics Inc. (BLPH)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
BLPH Insider Trading Transactions for Bellerophon Therapeutics Inc.
Goto page 0, 1, 2, 3, 4, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-05-21
Purchase
2019-05-22
11:14 am
Bellerophon Therapeutics Inc. BLPH Peacock Jonathan M
Director
20,000 $0.6099 $12,198 1,875,920
(Direct)
View
2019-05-21
Purchase
2019-05-22
11:15 am
Bellerophon Therapeutics Inc. BLPH Wang Theodore T
Director
10% Owner
43,280 $0.6093 $26,371 506,979
(Direct)
View
2019-05-22
Purchase
2019-05-24
09:30 am
Bellerophon Therapeutics Inc. BLPH Wang Theodore T
Director
10% Owner
27,500 $0.6012 $16,533 534,479
(Direct)
View
2019-06-12
Purchase
2019-06-14
11:46 am
Bellerophon Therapeutics Inc. BLPH Wang Theodore T
Director
10% Owner
50,000 $0.6381 $31,905 584,479
(Direct)
View
2019-10-24
Sale
2019-10-28
5:15 pm
Bellerophon Therapeutics Inc. BLPH VENROCK ASSOCIATES IV L P
VENROCK ENTREPRENEURS FUND IV L P
VEF Management IV LLC
Koh Bong Y
Venrock Healthcare Capital Partners II L.P.
Venrock Management IV LLC
Venrock Partners Management LLC
Venrock Partners L.P.
VHCP Co-Investment Holdings II LLC
VHCP Management II LLC
10% Owner
1,093,847 $0.47992 $524,957 6,435,173
(Indirect)
View
2019-10-24
Sale
2019-10-28
5:17 pm
Bellerophon Therapeutics Inc. BLPH VENROCK ASSOCIATES IV L P
Venrock Healthcare Capital Partners III L.P.
VHCP Co-Investment Holdings III LLC
Shah Nimish P
VHCP Management III LLC
10% Owner
1,093,847 $0.47992 $524,957 6,435,173
(Indirect)
View
2019-11-21
Purchase
2019-11-25
4:52 pm
Bellerophon Therapeutics Inc. BLPH Wang Theodore T
Director
10% Owner
8,443 $0.38389 $3,241 592,922
(Direct)
View
2020-06-05
Purchase
2020-06-09
4:01 pm
Bellerophon Therapeutics Inc. BLPH Wang Theodore T
Director
10% Owner
7,586 $12.77 $96,896 60,913
(Direct)
View
2020-09-10
Purchase
2020-09-14
08:31 am
Bellerophon Therapeutics Inc. BLPH FARES Wassim
Chief Medical Officer
4,000 $10.18 $40,708 4,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-05-22
Tax Withholding
2019-05-23
4:46 pm
N/A
N/A
Bellerophon Therapeutics Inc. BLPH Edmonds Amy
VP
35,827 $0.6084 140,216
(Direct)
View
2019-06-06
Option Award
2019-06-10
4:46 pm
N/A
2029-06-06
Bellerophon Therapeutics Inc. BLPH Teufel Crispin
Director
25,000 $0.59 25,000
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:39 pm
N/A
2029-09-26
Bellerophon Therapeutics Inc. BLPH Edmonds Amy
VP
175,500 $0.5 445,886
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:48 pm
2020-09-26
2029-09-26
Bellerophon Therapeutics Inc. BLPH BENNETT MATTHEW
Director
46,266 $0.5 84,482
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:50 pm
2020-09-26
2029-09-26
Bellerophon Therapeutics Inc. BLPH Amin Naseem
Director
46,266 $0.5 109,482
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:50 pm
N/A
2029-09-26
Bellerophon Therapeutics Inc. BLPH Korner Assaf
CFO
175,500 $0.5 425,500
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:51 pm
2020-09-26
2029-09-26
Bellerophon Therapeutics Inc. BLPH Bruder Scott P
Director
46,266 $0.5 129,482
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:51 pm
2020-09-26
2029-09-26
Bellerophon Therapeutics Inc. BLPH Cloyd Mary Ann
Director
46,266 $0.5 119,482
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:52 pm
N/A
2029-09-26
Bellerophon Therapeutics Inc. BLPH Dekker Martin
VP
175,500 $0.5 438,483
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:52 pm
N/A
2029-09-26
Bellerophon Therapeutics Inc. BLPH Tenenbaum Fabian
CEO
1,752,000 $0.5 5,440,697
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:53 pm
N/A
2029-09-26
Bellerophon Therapeutics Inc. BLPH Fernandes Peter
Chief Regulatory & Safety Offr
175,500 $0.5 470,290
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:53 pm
2020-09-26
2029-09-26
Bellerophon Therapeutics Inc. BLPH Moura Andre V.
Director
46,266 $0.5 104,482
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:53 pm
N/A
2029-09-26
Bellerophon Therapeutics Inc. BLPH Shah Parag Suresh
VP
175,500 $0.5 445,854
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:54 pm
2020-09-26
2029-09-26
Bellerophon Therapeutics Inc. BLPH Teufel Crispin
Director
46,266 $0.5 71,266
(Direct)
View
2019-09-26
Option Award
2019-09-30
4:54 pm
2020-09-26
2029-09-26
Bellerophon Therapeutics Inc. BLPH Wang Theodore T
Director
10% Owner
46,266 $0.5 109,482
(Direct)
View
2019-11-15
Tax Withholding
2019-11-19
4:35 pm
N/A
N/A
Bellerophon Therapeutics Inc. BLPH Korner Assaf
CFO
32,987 $0.34 66,078
(Direct)
View
2019-11-15
Tax Withholding
2019-11-19
4:35 pm
N/A
N/A
Bellerophon Therapeutics Inc. BLPH Dekker Martin
VP
27,134 $0.34 124,619
(Direct)
View
2019-11-15
Tax Withholding
2019-11-19
4:36 pm
N/A
N/A
Bellerophon Therapeutics Inc. BLPH Tenenbaum Fabian
CEO
76,823 $0.34 407,459
(Direct)
View
2019-11-15
Tax Withholding
2019-11-19
4:36 pm
N/A
N/A
Bellerophon Therapeutics Inc. BLPH Fernandes Peter
Chief Regulatory & Safety Offr
40,280 $0.34 182,022
(Direct)
View
2019-11-15
Tax Withholding
2019-11-19
4:36 pm
N/A
N/A
Bellerophon Therapeutics Inc. BLPH Shah Parag Suresh
VP
25,993 $0.34 105,606
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:51 pm
N/A
N/A
Bellerophon Therapeutics Inc. BLPH Peacock Jonathan M
Director
350,000 $0 2,225,920
(Direct)
View
2020-04-17
Other
2020-04-20
10:47 am
N/A
N/A
Bellerophon Therapeutics Inc. BLPH Puissance Cross-Border Opportunities III LLC
Puissance Capital Fund (GP) LLC
Puissance Capital Management LP
Puissance Capital Management (GP) LLC
Wang Theodore T
10% Owner
553,250 $0 0
(Indirect)
View
2020-05-21
Option Award
2020-05-22
07:25 am
N/A
N/A
Bellerophon Therapeutics Inc. BLPH Puissance Life Science Opportunities Fund VI
Puissance Capital Fund (GP) LLC
Puissance Capital Management LP
Puissance Capital Management (GP) LLC
Wang Theodore T
10% Owner
1,153,846 $13 1,153,846
(Direct)
View
2020-09-10
Option Award
2020-09-14
4:02 pm
2021-09-10
2030-09-10
Bellerophon Therapeutics Inc. BLPH Amin Naseem
Director
6,509 $10.12 15,138
(Direct)
View
2020-09-10
Option Award
2020-09-14
4:02 pm
2021-09-10
2030-09-10
Bellerophon Therapeutics Inc. BLPH Bruder Scott P
Director
6,509 $10.12 15,138
(Direct)
View
2020-09-10
Option Award
2020-09-14
4:02 pm
2021-09-10
2030-09-10
Bellerophon Therapeutics Inc. BLPH Cloyd Mary Ann
Director
6,509 $10.12 14,472
(Direct)
View
2020-09-10
Option Award
2020-09-14
4:03 pm
2021-09-10
2030-09-10
Bellerophon Therapeutics Inc. BLPH BENNETT MATTHEW
Director
6,509 $10.12 6,509
(Direct)
View
2020-09-10
Option Award
2020-09-14
4:03 pm
2021-09-10
2030-09-10
Bellerophon Therapeutics Inc. BLPH Moura Andre V.
Director
6,509 $10.12 13,472
(Direct)
View
2020-09-10
Option Award
2020-09-14
4:03 pm
2021-09-10
2030-09-10
Bellerophon Therapeutics Inc. BLPH Teufel Crispin
Director
6,509 $10.12 11,259
(Direct)
View
2020-09-10
Option Award
2020-09-14
4:04 pm
2021-09-10
2030-09-10
Bellerophon Therapeutics Inc. BLPH Wang Theodore T
Director
10% Owner
6,509 $10.12 13,806
(Direct)
View
2020-09-10
Option Award
2020-09-14
4:04 pm
N/A
2030-09-10
Bellerophon Therapeutics Inc. BLPH FARES Wassim
Chief Medical Officer
30,000 $10.12 30,000
(Direct)
View
Goto page 0, 1, 2, 3, 4, Next